Regenxbio is pushing its Duchenne muscular dystrophy gene therapy into pivotal development, with a BLA planned for ...

Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

From a new market intelligence platform to an AI-powered smart wallet, these technologies are changing the way we think of ...

Robert F. Kennedy Jr.'s nonprofit, Children’s Health Defense, is involved in vaccine lawsuits against agencies he could wind ...

Pfizer Korea Country Manager Oh Dong-wook gives an opening speech at a press event regarding the regulatory approval of ...

A Las Vegas couple has filed a lawsuit against the pharmaceutical giant Pfizer and other generic manufacturers for one of their birth control products.

A Las Vegas couple has filed a lawsuit against the pharmaceutical giant Pfizer and other generic manufacturers for one of their birth control products.

Biotech-stock investing has one tough test for success - and it's about to get easier ...

A woman who claims she developed multiple brain tumors from using Depo-Provera is now suing Pfizer and several generic drug manufacturers in Nevada's District Court.

Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

Experts warn of an expected winter COVID-19 surge, potentially impacting marginalized communities that have faced disproportionate effects since the pandemic began. Health advocates emphasize the need ...

Regenxbio’s investigational gene therapy improved muscle function for patients with Duchenne muscular dystrophy (DMD) in a phase 1/2 study. | Regenxbio’s investigational gene therapy improved muscle ...